SEC 13F Intelligence

Peakshares LLC / REGN

Peakshares LLC’s Regeneron Pharmaceuticals Position

Does Peakshares LLC own Regeneron Pharmaceuticals (REGN)? Yes1.4K shares worth $1M (+1.03% of its 13F portfolio) as of Q1 2026.

Position Value
$1M
Q1 2026
Shares
1.4K
% of Portfolio
+1.03%
Quarters Held
1
currently held

Position History REGN

Reported value by quarter
Q1 ’26: $1MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.4K$1M+1.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peakshares LLC’s full portfolio or all institutional holders of REGN.